(A) Primary mouse macrophages were cultured in 24-well plate (1,000,000 cells per well). Cells were pre-treated with ANO1 activator, Eact (10, 30 M) for 24 h, followed by stimulation with 0.1 g/mL LPS to induce TNF- release. After 24 h of LPS stimulation, levels of TNF- in culture supernatants were measured by ELISA. The data are presented as means ± SEM (n = 9). ** p < 0.01, *** p < 0.001. Activation of ANO1 by Eact inhibits LPS-induced TNF- production in a dose-dependent manner.
(B) The relative mRNA expression of TNF- and ANO1 was examined using qPCR and data are presented after being normalized to -actin (means ± SEM; n = 4 ). * p < 0.05. LPS up-regulated the mRNA expression of TNF-, and down-regulated the mRNA expression of ANO1. Eact dosedependently inhibited the expression of TNF- induced by LPS-stimulation in primary mouse macrophages. Figure S6 . TNF- down-regulates ANO1 expression in PC-3 cells. PC-3 cells were cultured in 6-well plate (100,000 cells per well) and were treated with different concentrations of human recombinant TNF- (10 pg/ml, 10 ng/ml, and 10 g/ml). After 24 h of treatment, the relative protein and mRNA expression of ANO1 was measured using western blot and qPCR. The data are presented after being normalized to -actin (means ± SEM; n = 4; * p < 0.05, ** p < 0.01). Human recombinant TNF- decreases ANO1 expression in PC-3 cells.
Figure S7. Verification of TNF-R1 and TRADD expression.
Immunoblots of lysates from prostate cells as described. Data are expressed as means ± SEM. There was no significant change observed in TNFR1 (n = 3) and TRADD (n = 5) expression in either PC-3 cells or RWPE-1 cells. log2Ratio > 0 means up-regulation, log2Ratio < 0 means down-regulation 
